US2017165312A1PendingUtilityA1
Modulation of oxidative stress, inflammation, and impaired insulin sensitivity with grape seed extract
Est. expiryApr 10, 2032(~5.7 yrs left)· nominal 20-yr term from priority
A61K 36/87A61K 31/353A61K 31/192
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Method for modulating oxidative stress, inflammation, and impaired insulin sensitivity in a subject by using a grape seed extract, the method being useful in modulating post-prandial oxidative stress, inflammation, and impaired insulin sensitivity in patients suffering from Metabolic Syndrome (MetS). The method comprising administering a therapeutically effective amount of a grape seed extract and a pharmaceutically acceptable excipient. The grape seed extract is a polyphenolic extract comprising proanthocyanidins and anthocyanidins.
Claims
exact text as granted — not AI-modified1 - 24 . (canceled)
25 . A method for preventing Metabolic Syndrome in a subject comprising administering a therapeutically effective amount of a grape seed extract to the subject.
26 . (canceled)
27 . The method of claim 25 , wherein the grape seed extract is a polyphenolic extract comprising 4-11° A monomers, 4-9% dimers, 2-4% trimers, 1-4% tetramers, and 1′)/0 or less of pentamers expressed as % by weight as epicatechin equivalents, and having an epicatechin gallate terminal unit content of 5wt% or more.
28 . The method of claim 27 , wherein the grape seed extract has 0-2wt% of free gallic acid.
29 . The method of claim 27 , wherein the grape seed extract comprises 12wt% or more epicatechin gallate units.
30 . The method of claim 27 , wherein the grape seed extract comprises 5.7% gallic acid, 6.7% catechin, 4.8% epicatechin, 34.4% dimer B, and 46.1% polymer.Join the waitlist — get patent alerts
Track US2017165312A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.